Related Business Topics
Latest Headlines
Reuters - Mar. 11, 2010, 2:23 AM
Symphony entity Zenith Pharma, which held 30.96% in Strides as of December 2009, has sold shares worth Rs 72 crore. Symphony Capital-owned investment entity Zenith Pharmaceuticals has started encashing its over eight-year-old investment in ...
Reuters - Mar. 7, 2010, 9:07 AM
FRANKFURT, March 7 (Reuters) - Pfizer Inc (PFE.N Jeff Kindler and an array of top-rank managers at the world's biggest drugmaker arrived on Friday in the southern German town of Ulm, where Ratiopharm is based, for a closed-door presentation on their ...
Reuters - Mar. 7, 2010, 8:30 AM
FRANKFURT, March 7 (Reuters) - Pfizer Inc (PFE.N Jeff Kindler and an array of top-rank managers at the world's biggest drugmaker arrived on Friday in the southern German town of Ulm, where Ratiopharm is based, for a closed-door presentation on their ...
Reuters - Mar. 7, 2010, 8:27 AM
FRANKFURT, March 7 (Reuters) - Pfizer Inc <PFE.N> wheeled out its chief executive and pledged to invest in growth as it sought to win the bidding to buy German generic drugmaker Ratiopharm GmbH, sources familiar with the situation said. Jeff Kindler and ...
Reuters - Mar. 5, 2010, 6:38 AM
Aspen facility manufactures penems and penicillins, and is forcasted to deliver products of $40 mn annually. Strides Arcolab Ltd, a Bangalore-based drug-maker, is acquiring a facility center of Aspen, a pharmaceutical products manufacturing company in ...
Wall Street Journal Online - Mar. 4, 2010, 2:20 AM
Reuters - Mar. 3, 2010, 9:33 PM
The facility makes Penems and Penicillins and is forecasted to deliver $40 million on an annualised basis, it said in a statement to NSE. 'Penems and Penicillins form an important part of Strides speciality injectable business and licencing agreements ...
Reuters - Mar. 3, 2010, 9:14 PM
The facility is forecasted to deliver $40 million on an annualised basis, it said in a statement to ...
Reuters - Mar. 3, 2010, 6:17 AM
* Neck-and-neck bids of about 3 bln eur by suitors-sources * Decision unlikely before the end of March-source * Pfizer's Frankfurt-listed shares were down 0.85 pct * Teva's Tel Aviv-listed shares were up 0.61 percent NEW YORK/FRANKFURT, March 3 (Reuters) ...
Reuters - Feb. 16, 2010, 10:47 AM
FRANKFURT, Feb 16 (Reuters) - The field of bidders for Germany's second-largest generic-drug maker, Ratiopharm, will be narrowed to one or two contestants this week, people familiar with the auction have told Reuters. [ID:nLDE61E1M5] Here is how buying ...
